Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer

Table 1

Correlation of TSP50 protein expression with clinicopathological parameters.

Patients features	All cases	TSP50 protein expression
		High expression	Low expression	𝑃 value^a
Gender
Male	233	138 (59.2%)	95 (40.8%)	0.252
Female	101	53 (52.5%)	48 (47.5%)
Age at surgery
≥57^b	172	84 (48.8%)	88 (51.2%)	0.001
<57	162	107 (66.0%)	55 (34.0%)
Tumor size
≥5 cm	149	84 (56.4%)	65 (43.6%)	0.788
<5 cm	185	107 (57.8%)	78 (42.2%)
Histological type
Intestinal	265	142 (53.6%)	99 (46.4%)	0.582
Diffuse	69	38 (55.1%)	31 (44.9%)
TNM
I + II	117	49 (41.9%)	68 (58.1%)	0.000
III + IV	217	142 (65.4%)	75 (34.6%)
Lymph node metastases
Present	234	146 (62.4%)	88 (37.6%)	0.003
Absent	100	45 (45.0%)	55 (55.0%)

aChi square test; bmedian age.